About Astrophel Pharmaceuticals
Astrophel Pharmaceuticals was a Healthcare company based in Mumbai (India) founded in 2013 by Pradeep Tukaram More, Rohit Dilip Sadre, and Rashmikant Vijpar Shah. Manufacturer of branded generics for cardiology and diabetology segments. It operates on a Traditional Pharmaceuticals model. The company has 1 employees. Its Indian entity Astrophel Pharmaceuticals Private Limited reported revenue of ₹3.35 Cr. The company is recorded as dissolved. Astrophel Pharmaceuticals offers products and services including Astrophel Pharmaceuticals Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified.
Company details
Astrophel Pharmaceuticals, founded in 2013 in Mumbai, India, focuses on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of branded generics for cardiology and diabetology segments. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Mumbai, India
- Employees 1
- Founders Pradeep Tukaram More, Rohit Dilip Sadre, Rashmikant Vijpar Shah
- SectorsHealthcare
- Website astrophelpharma.com/index.php
- Legal Name Astrophel Pharmaceuticals Private Limited
- Date of Incorporation 07 Sep, 2013
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹3.35 Cr
FY 2018 · +24% YoY
- Net Loss-₹29.2 Lakh
FY 2018 · -9% margin
- EBITDA₹14,895
FY 2018 · 0% margin
- Employee Count1
Associated legal entities of Astrophel Pharmaceuticals
Astrophel Pharmaceuticals operates through Astrophel Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2018) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Astrophel Pharmaceuticals Private Limited CIN U74999MH2013PTC248004 | Active | 07 Sep 2013 | Mumbai, Maharashtra | ₹3.3 Cr | 2 | View details |
Products & Services of Astrophel Pharmaceuticals
Astrophel Pharmaceuticals offers a comprehensive portfolio of products and services, including Astrophel Pharmaceuticals Platform.
Manufacturer of branded generics for cardiology and diabetology segments
Board of directors of Astrophel Pharmaceuticals Private Limited (Astrophel Pharmaceuticals)
Astrophel Pharmaceuticals Private Limited is the primary company behind Astrophel Pharmaceuticals. The board of Astrophel Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Rajesh Vijpar Shah, appointed in 2013. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajesh Vijpar Shah DIN 02611273 | Director | 07 Sep 2013 | 13 yrs 1 mo | Astrophel Pharmaceuticals Private Limited |
| Pradeep Tukaram More DIN 06502347 | Director | 07 Sep 2013 | 13 yrs 1 mo | Astrophel Pharmaceuticals Private Limited |
People of Astrophel Pharmaceuticals
3 people are tracked at Astrophel Pharmaceuticals (3 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Co-Founder & Director | Leadership | |
| Co-Founder & Director | Leadership | |
| Co-Founder & Director | Leadership |
Complete people profiles for Astrophel Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Astrophel Pharmaceuticals
Figures of Astrophel Pharmaceuticals Private Limited, the primary company behind Astrophel Pharmaceuticals, for FY 2018. Revenue was ₹3.35 Cr (+24% year on year). Net loss was -₹29.2 Lakh (-9% margin). EBITDA was ₹14,895 (0% margin).
- ₹3.35 CrRevenue · FY 2018 · +24% YoY
- -₹29.2 LakhNet loss · -9% margin
- ₹14,895EBITDA · 0% margin
- ₹15 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Astrophel Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Astrophel Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Astrophel Pharmaceuticals
Astrophel Pharmaceuticals was founded in 2013.
Astrophel Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Astrophel Pharmaceuticals has 1 employees.
The primary company behind Astrophel Pharmaceuticals, Astrophel Pharmaceuticals Private Limited, reported revenue of ₹3.35 Cr for FY 2018, up 24% year on year.
Astrophel Pharmaceuticals, founded in 2013 in Mumbai, India, focuses on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of branded generics for cardiology and diabetology segments. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Astrophel Pharmaceuticals offers Astrophel Pharmaceuticals Platform.
Astrophel Pharmaceuticals operates through Astrophel Pharmaceuticals Private Limited.
The legal entities of Astrophel Pharmaceuticals currently have 2 directors, including Rajesh Vijpar Shah, Pradeep Tukaram More.